---
schema_version: "secwatch.filing_event.v1"
accession: "0001185185-26-000032"
form_type: "8-K"
ticker: "IGC"
cik: "0001326205"
company_name: "IGC Pharma, Inc."
filed_at: "2026-01-06T23:59:59+00:00"
generated_at: "2026-05-16T11:30:06.441327+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# IGC Pharma raises ~$234k in registered direct offering of 780k shares at $0.30/share

## Summary
- Issued 779,997 shares of common stock at $0.30 per share for gross proceeds of ~$234k.
- Offering closed on or about January 5, 2026 under existing shelf registration statement.
- Net proceeds to fund working capital, clinical development, R&D, and other business initiatives.

## SEC filing metadata
- accession: 0001185185-26-000032
- form_type: 8-K
- ticker: IGC
- cik: 0001326205
- company_name: IGC Pharma, Inc.
- filed_at: 2026-01-06T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1326205/000118518526000032/0001185185-26-000032-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1326205/000118518526000032/igc8k010526.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001185185-26-000032
- JSON: https://secwatch.observer/filing/0001185185-26-000032.json
- Plain text: https://secwatch.observer/filing/0001185185-26-000032.txt

## Key facts
- Material Agreements
  IGC Pharma, Inc. entered into 2025 Subscription Agreement with certain investors valued at approximately $234 thousand (effective 2026-01-05).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: certain investors
  - Value: approximately $234 thousand
  - Effective: 2026-01-05
  source text: entered into a Subscription Agreement (the “2025 Subscription Agreement”) with certain investors named therein (collectively, the “Investors”), pursuant to which the Company agreed to issue and sell to the Investors, in a registered direct offering (the “Offering”), an aggregate of 779,997 shares of the Company’s common stock
  evidence_url: https://www.sec.gov/Archives/edgar/data/1326205/000118518526000032/0001185185-26-000032-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.